Most Asian markets bounced on Monday following last week's blood-letting as bargain-buyers moved in, but dealers remain on edge as surging infections and a stuttering vaccination rollout offset long-term hopes for the economic recovery.
Patients of Asian and black backgrounds suffered disproportionate rates of premature death from COVID-19, according to a study of 1,737 patients by Queen Mary University of London and Barts Health NHS Trust.
Northeastern Asia has a complex history of migrations and plague outbursts. That is the essence of an international archeogenetic study published in Science Advances and lead from the Department of Archaeology and Classical Studies at Stockholm University, Sweden.
The Asian tiger mosquito does not pose a major risk for Zika virus epidemics, according to a study published in the open-access journal PLOS Pathogens by Albin Fontaine of the Institut de Recherche Biomédicale des Armées, and colleagues.
Asian firms turned most optimistic in the fourth quarter this year, a Thomson Reuters/INSEAD survey showed, as business activity picked up in the region and COVID-19 vaccines started rolling out in Western countries ahead of their Asian launch.
Asian markets mostly rose on Wednesday but investors were shifting cautiously as they weighed hopes for a virus vaccine against surging infections around the world that threaten an already stuttering economic recovery.
Shares advanced Tuesday in Asia after hopes for fresh economic stimulus helped Wall Street recover its losses from the initial shock of learning President Donald Trump had tested positive for the coronavirus.
Asian shares stumbled on Monday and oil prices slipped as fears of a second wave of coronavirus infections in Beijing sent investors scurrying for safe-havens while underwhelming data from China further weighed on sentiment.